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Abstract
The aim of this cross-sectional study was to investigate the 
relationship between body mass index (BMI), waist-to-hip ratio, 
and lipid parameters and serum thyroid-stimulating hormone 
(TSH) levels in healthy euthyroid individuals.
This cross-sectional study was conducted between June 1st and 
July 20th, 2013, at Bushehr University of Medical Sciences. 
One hundred forty euthyroid individuals were divided into 2 
groups: a high-TSH group (TSH between 2.0 and 5.5 mIU/L, 
n=67) and a low-TSH group (TSH between 0.3 and 2.0 mIU/L, 
n=73). After overnight fast, total cholesterol, triglyceride (TG), 
high-density lipoprotein cholesterol (HDL-C), low-density 
lipoprotein cholesterol (LDL-C), TSH, thyroxine (T4), and 
triiodothyronine (T3) were measured. Height and weight were 
measured with a stadiometer, and BMI was calculated as weight 
in kilograms divided by the square of height in meters. Waist-
to-hip ratio was determined as waist circumference divided by 
hip circumference. The simple independent t-test and a general 
linear model were used for statistical analysis. All statistical 
analyses were done using the SPSS, version 15, statistical 
software package.
BMI and LDL-C were significantly higher in the high-TSH 
group than in the low-TSH group after adjustment for age, sex, 
calorie intake, total fat and carbohydrate intakes, and physical 
activity. No significant differences were found between the 
groups in TG, cholesterol, and HDL-C. The association between 
TSH levels andT4 was significant.
Individuals with TSH levels at the upper limit of normality 
might be at risk of hypercholesterolemia and obesity.
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Introduction
Recently, public health researchers have shown increased 
interest in the role of obesity in health and disease. Obesity is 
a complicated process that depends on signals of satiety and 
hunger, genetics, endocrine abnormalities, and other factors.1 
Among these potential contributing factors, hypothyroidism is 
Brief Report
What’s Known
• The normal range for TSH (0.2-5.5 
mIU/L) is used in many laboratories to 
document normal thyroid function. TSH 
level beyond normal range correlate 
significantly with obesity indices and 
dyslipidemia in subclinical hypothyroid 
(elevated TSH, Normal T3, T4) and 
overt hypothyroid (elevated TSH, 
Decreased T3, T4) individuals.
What’s New
• In healthy euthyroid individuals 
without overt or subclinical 
hypothyroidism, BMI and LDL-C were 
significantly higher in the high-TSH 
group than in the low-TSH group after 
adjustment for age, sex, calorie intake, 
total fat and carbohydrate intakes, and 
physical activity.
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one of the main causes. The activity of the 
thyroid gland is regulated by thyrotropin or 
thyroid-stimulating hormone (TSH), which is 
secreted by the pituitary gland.2 However, the 
association between TSH levels per se and 
obesity has remained controversial. The normal 
range for TSH (0.2–5.5 mIU/L)3 is used in many 
laboratories to document normal thyroid function; 
however, individuals with TSH levels >2.0 mIU/L 
have been found to be at increased risk of 
dyslipidemia, obesity, and overt hypothyroidism.3 
The relationship between TSH levels and 
obesity or dyslipidemia in subclinical and overt 
hypothyroidism has been proven.4 Nonetheless, 
the relationship between TSH and obesity or 
dyslipidemia in individuals with normal TSH and 
without overt or subclinical hypothyroidism is 
obscure and few studies to date have focused 
on this relationship in euthyroid individuals. 
The novelty and the goal of this study was to 
investigate the relationship between TSH levels 
in healthy euthyroid individuals and their obesity 
indices (body mass index [BMI] and waist-to-hip 
ratio [WHR]) and lipid parameters.
Patients and Methods
Study Participants
This cross-sectional study was conducted 
between June 1st and July 20th, 2013, at Bushehr 
University of Medical Sciences, in Bushehr, Iran. 
Eligible patients willing to participate in the study 
were selected from the population of individuals 
referred to the medical offices in Bushehr.
The participants were invited to come to the 
Persian Gulf Tropical Medicine Research Center 
in Bushehr University of Medical Sciences on 
the following morning in a letter that explained 
the objectives of the study and was delivered 
to their homes by the research team. Signed 
informed consent was obtained from each 
participant. The criteria for inclusion in the study 
were TSH levels between 0.4 and 5.5 mIU/L.3 
Potential participants were interviewed and 
examined by an endocrinologist and excluded 
if they were using cigarettes, thyroid drugs, 
estrogen, or medications for hypertension or 
had any clinical signs of dyslipidemia, diabetes 
mellitus, or hypothyroidism such as feeling cold, 
hoarse voice, dry skin, malaise, puffy eyes, 
poor memory, constipation, muscle weakness 
or cramps, and slow thinking. Of 950 persons 
who were willing to participate in the study, 140 
were eligible. This sample size was based on the 
results of a previous study5 and was calculated 
by using G*Power (version 3.1, Informer 
Technologies, Inc.). With a population of 140 
individuals, the power of the study will be 90%. 
We divided the participants into 2 groups: a high-
TSH group with TSH between 2.0 and 5.5 mIU/L3 
(n=67) and a low-TSH group with TSH between 
0.3 and 2.0 mIU/L3 (n=73).
Then a blood sample was obtained from each 
participant and transferred to the laboratory of the 
Persian Gulf Tropical Medicine Research Center, 
where plasma total cholesterol (TC), triglyceride 
(TG), high-density lipoprotein cholesterol (HDL-
C), low-density lipoprotein cholesterol (LDL-C), 
TSH, thyroxine (T4), and triiodothyronine (T3) 
levels were determined.
Anthropometric Measurements
Height and weight in the participants were 
measured with a stadiometer. Heavy outer 
garments and shoes were removed before 
height and weight were measured. BMI was 
calculated as weight in kilograms divided by 
the square of height in meters (kg/m2). Waist 
circumference was measured with a non-
stretchable measuring tape at the midpoint 
between the lower edge of the rib cage and 
the iliac crests. WHR was determined as waist 
circumference divided by hip circumference. For 
this parameter, waist circumference was defined 
as the smallest circumference measured at the 
navel, and hip circumference was defined as the 
largest circumference measured at the hips and 
buttocks.
Physical Activity
Physical activity in the participants was 
evaluated using a validated questionnaire 
based on the International Physical Activity 
Questionnaire, 2005, Epic-Norfolk.6
Dietary Intake Analysis
Dietary intake at the time of the study was 
recorded in an interview conducted by trained 
dietitian using a food frequency questionnaire 
(FFQ). In addition, all men and women completed 
a 24-hour dietary recall for 3 nonconsecutive 
days. The FFQ showed a correlation 
coefficient of 0.85 with 24-hourdietary recall. 
The reproducibility and relative validity of the 
168-item FFQ had been tested previously in the 
Tehran Lipid and Glucose Study.7 Each food and 
beverage was analyzed for the content of energy 
and other nutrients with Nutritionist III software 
(version 7.0; N-Squared Computing, Salem, 
OR, USA), which was adapted for Iranian foods. 
All statistical analyses were done with an IBM 
computer using the SPSS, version 15, statistical 
software package (SPSS Inc., Chicago, IL, 
USA).
The experimental protocol of the study 
was approved by the Research Deputyship 
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of Bushehr University of Medical Sciences 
(DP/8703277/176, 14/4/2013). The ethical 
aspects of the study were also approved by 
the Ethics Committee of Bushehr University of 
Medical Sciences (May 2013), and the research 
reported here was carried out in accordance 
with the principles of the Declaration of Helsinki 
as revised in 2000.
Measurement of Serum Parameters
Venous blood samples were obtained 
between 8.00 and 9.00 hours and centrifuged at 
3,000 g for 15 minutes at 4 °C. Immediately after 
centrifugation, the serum samples were frozen 
and stored at –80 °C for a period no longer than 
6 weeks. To detect TSHin the serum samples, 
we used a commercially available ELISA kit 
(Autobio, Zhengzhou, China 450016, Catalog 
#E1003) according to the manufacturer’s 
instructions. The limit of the detection of the 
assay was 0.05 mIU/L, and the intra- and inter-
assay coefficients of variance were 5.19%–
6.54% and 7.36%–8.23%, respectively. Total 
plasma T4 was determined with a commercially 
available ELISA kit (Pishtaz Teb CO. LTD., Arak, 
Iran). Total plasma T3 was also measured with 
a commercially available ELISA kit (Pishtaz Teb 
CO. LTD., Arak, Iran). Serum TG was measured 
with an enzymatic technique for oxidation by 
glycerol-3 phosphate and detection with phenol 
aminoantipyrine in an automated Technicon 
Axon Analyzer. HDL-C concentrations (after 
precipitation with magnesium chloride) were 
measured with enzymatic techniques (Pars 
Azmoon Co., Tehran, Iran). LDL-C concentrations 
were calculated with the Friedewald formula.8
Statistical Analysis
The distribution of the variables was studied 
with probability plots and the Shapiro–Wilk test. 
To identify differences between the 2 groups 
in BMI, WHR, and serum lipid parameters, we 
used the simple independent Student t-test. The 
general linear model was employed to adjust 
the differences between the 2 groups for age, 
sex, physical activity, total calorie intake, total 
dietary fat, and total dietary carbohydrates. 
The relationship between TSH and T4 or T3 
was determined by calculating the Pearson 
correlation coefficient. Multiple linear regression 
models were utilized to determine the association 
between TSH and circulating T3 or T4 levels with 
adjustment for age and sex. A value of P<0.05 
was accepted as significant.
All statistical analyses were done with an IBM 
computer and the SPSS, version 15, statistical 
software package (SPSS Inc., Chicago, IL, 
USA).
Results
The characteristics of the participants in the 
2 groups are shown in table 1. Overall, the 
prevalence of overweight and obesity (BMI>25) 
was 53.2% and mean±SD age was 29±14 years.
The independent Student t test showed no 
significant differences between the 2groups in 
age, sex, T3, T4, calorie intake, and carbohydrate 
or total fat intake (table 1). Table 2 shows that 
BMI and LDL-C were significantly higher in the 
high-TSH group than in the low-TSH group 
before and after adjustment for age, sex, calorie 
intake, total fat, total carbohydrates, and physical 
activity. No significant differences between the 
groups were found for TG, cholesterol, and 
HDL-C.
The bivariate correlation analysis showed 
a correlation between serum TSH levels and 
T4 levels (r=-0. 3, P=0.01). The association 
between TSH levels and T4 was determined with 
the multiple linear regression analysis. There 
was a significant negative association between 
TSH and T4 levels. This significant relationship 
persisted after adjustment for age and sex 
(table 3). There was no association between 
TSH and T3 levels.
Discussion
Our findings showed that the euthyroid individuals 
whose TSH concentrations were>2.0 mIU/L had 
a higher BMI than those with lower TSH levels. 
This finding is consistent with a large population 
study that found a significant positive association 
between TSH and BMI, although in this study the 
participants’ TSH levels were within the normal 
range.9 The ligand of TSH and the TSH receptors, 
located on adipose cell membranes, mediates 
adipocyte proliferation.10 In fact, one possible 
explanation for the increased TSH levels in 
Table 1: Characteristics of the individuals (N=140)
Characteristics Low-TSH 
Group
High-TSH 
Group
P value
Age (y) 34.61±15.43 31.39±16.38 0.15
Sex
Female 48 45 0.23
Male 25 22 0.34
TSH 1.2±0.31 3.65±0,45 0.03
T4 (µg/dL) 9.13±2.63 8.44±2.07 0.08
T3(ng/dL) 70.28±19.52 60.80±27.17 0.93
Calorie intake (Kc) 3205±811 3165±690 0.56
Carbohydrate (g/d) 394±197 382±151 0.93
Total fat (g/d) 121±41 126±76 0.56
Data are presented as means±SD. 
TSH:Thyroid -stimulating hormone; T3: Triiodothyronine; 
T4: Thyroxine 
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obese individuals may be related with the effect 
of TSH on leptin secretion by adipocytes.11 In 
this connection, several epidemiological studies 
have found a positive relationship between TSH 
and leptin levels in humans.2 Antunes et al.12 
suggested that TSH released leptin by acting 
directly on the adipocytes and that elevated 
leptin might explain the linkage between TSH 
and obesity by inducing insulin resistance. 
It should be noted that obesity is the result of 
adipocyte hypertrophy and hyperplasia,13 and 
insulin controls the volume and number of 
adipocytes.13
The relationship between obesity and TSH 
may also be involved in the correlation between 
TSH levels and other thyroid hormone levels. It 
should be borne in mind that TSH has a very 
short half-life (<1 h) compared to the half-
lives of T4 (7 d) and T3 (1 d).4 Serum TSH 
concentrations return rapidly to normal values if 
serum T4 and T3 remain within normal levels. 
In contrast, serum TSH remains elevated in the 
upper normal range if thyroid hormone levels are 
not stable enough throughout the day to restore 
physiological secretion rates in the pituitary 
gland. The elevated serum TSH levels in our 
apparently euthyroid individuals appeared to 
be inadequate to sustain tissue euthyroidism. 
In other words, in euthyroid individuals whose 
serum TSH concentrations are in the upper 
normal range, serum thyroid hormones might be 
not adequate to control metabolism throughout 
the day even though laboratory results show 
apparently normal values. Thyroid hormones 
use several metabolic pathways which are rel-
evant to resting energy expenditure.14 Therefore, 
euthyroid individuals with a serum TSH 
concentration in the upper normal range may in 
fact have a mild form of tissue hypothyroidism. 
Resting energy expenditure seems to be very 
sensitive to small fluctuations in TSH.
In the present study, we found that mean 
LDL-C concentration was higher in the high-
TSH group than the low-TSH group. The activity 
of enzymes such as cholesterol ester transfer 
protein, hepatic lipase, lipoprotein lipase, HMG-
CoA reductase, and the LDL receptor decreases 
after thyroid hormone deficiency appears.4 All 
individuals in our study had no abnormalities 
in their thyroid hormone profile; however, 
mean LDL-C concentration was higher in the 
high-TSH group than in the low-TSH group. To 
understand this inconsistency, we note that we 
also observed a significant inverse association 
between serum TSH concentrations and T4 
levels. This reflects the sensitivity of thyroid 
hormones to minor changes in the activities 
of the pituitary gland.15 When a small change 
occurs in TSH levels, even within the normal 
range, it can disrupt the balance in thyroid 
hormone secretion, which in turn can influence 
LDL-C metabolism. Therefore, increased LDL-C 
levels would be anticipated in the participants 
in our study whose serum TSH concentrations, 
albeit elevated, were still within the upper limit of 
normal reference values.
As a potential limitation of our study, we note 
that the results of cross-sectional studies do not 
establish causal relationships. However, they 
do reveal associations among variables that 
can suggest potential mechanisms of action 
and that are useful for generating hypotheses 
that merit further investigation in intervention 
studies.
Table 2: Differences of variables between the groups analyze with the t-test (unadjusted) and general linear model, 
univariate (adjusted for age, sex, physical activity, total calorie intake, total dietary fat, and total dietary carbohydrates)
Group
Characteristics
Low-TSH Group High-TSH Group P value (adjusted) P value (unadjusted)
BMI (kg/m2) 25.29±5.15 27.82±16.24 0.03 0.01
WHR 0.92±0.08 0.90±0.07 0.09 0.07
Chol (mg/dL) 178.63±42.19 179.56±41.37 0.80 0.87
LDL-C (mg/dL) 99.62±34.16 123.35±48.97 0.05 0.03
HDL-C (mg/dL) 47.50±12.20 48.18±22.07 0.89 0.98
TG (mg/dL) 153.86±81.29 163.92±123.56 0.72 0.83
T4 (µg/dL) 9.13±2.63 8.44±2.07 0.08 0.04
T3 (ng/dL) 70.28±19.52 60.80±27.17 0.93 0.98
BMI: Body mass index; WHR: Waist-to-hip ratio; TSH: Thyroid-stimulating hormone; T3: Triiodothyronine; T4: Thyroxine; 
TG: Triglyceride; Chol: Cholesterol; LDL-C: Low-density lipoprotein; HDL-C: High-density lipoprotein
Table 3: Multiple linear regression analysis for the 
association between TSH (independent variable) and T3 
and T4 (dependent variables) 
β P value
T3 Unadjusted −0.04 0.92
T3 Age-adjusted −0.05 0.97
T3 Age-sex adjusted −0.05 0.98
T4 Unadjusted −0.30 0.01
T4 Age-adjusted −0.33 0.01
T4 Age-sex adjusted −0.33 0.02
T3: Triiodothyronine; T4: Thyroxin
Body mass index serum lipid concentrations thyroid-stimulating hormone
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Conclusion
We conclude that individuals whose TSH levels 
are at the upper limit of the normal range might 
be at risk of hypercholesterolemia and obesity. 
However, we do not recommend the use of 
thyroid-modifying drugs to reduce weight or 
ameliorate LDL-C levels in these individuals.
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